Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 31
Phase 46

Trial Status

Completed5
Recruiting1
Other1

Role Distribution

Principal Investigator7
PI Rate100%

Activity Timeline

Clinical Trials (7)

NCT05332444Phase 4Recruiting
Efficacies of Susceptibility-guided vs Empiric Therapy for Rescue Treatment of Helicobacter Pylori Infection
Helicobacter Pylori Infection
PrincipalinvestigatorStart date: 2022-04-11
NCT03897244Phase 4Completed
Efficacies of HDDT With or Without Bismuth vs Amoxicillin-metronidazole BQT for First-line H Pylori Eradication
Helicobacter Pylori Infection
PrincipalinvestigatorStart date: 2019-05-30
NCT02490839Phase 4Completed
Efficacy of High-dose Dual Therapy vs Bismuth-containing Quadruple Therapy for Rescue Treatment of Hp Infection
Helicobacter Pylori Infection
PrincipalinvestigatorStart date: 2015-07-01
NCT01933659Phase 3Completed
Anti-H. Pylori Effect of Deep See Water
Helicobacter Pylori Infection
Principalinvestigator

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

National Taiwan University Hospital

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

David Y Graham, MD

Baylor College of Medicine

Moderately Similar
5 trials

Shared therapeutic areas:

Helicobacter Pylori InfectionHelicobacter Infections
Similarity Score30%

xiaojiao Li

The First Hospital of Jilin University

Related
4 trials

Shared therapeutic areas:

Helicobacter Pylori Infection
Similarity Score15%

Xiuli Zuo, MD,PhD

Qilu Hospital of Shandong University

Related
26 trials

Shared therapeutic areas:

Helicobacter Pylori Infection
Similarity Score15%

Eun Jung Jeon

The Catholic University of Korea

Related
1 trials

Shared therapeutic areas:

Helicobacter Pylori Infection
Similarity Score15%

Jyh-Ming Liou, MD, PhD

National Taiwan University Hospital

Related
3 trials

Shared therapeutic areas:

Helicobacter Pylori Infection

Worked with same sponsors:

National Taiwan University Hospital
Similarity Score15%

Ming-Cheh CHEN, MD

Buddhist Tzu Chi General Hospital

Related
4 trials

Shared therapeutic areas:

Helicobacter Pylori Infection
Similarity Score15%

Il Ju Choi, M.D., Ph.D.

National Cancer Center, Korea

Related
6 trials

Shared therapeutic areas:

Helicobacter Pylori Infection
Similarity Score15%

Ming-Shiang Wu, MD, PhD

National Taiwan University Hospital

Related
7 trials

Shared therapeutic areas:

Helicobacter Pylori Infection

Worked with same sponsors:

Ministry of Science and Technology, TaiwanNational Taiwan University Hospital
Similarity Score15%

Hyun Jeong Lee, fellow

Yeouido St. Mary's Hospital, The Catholic University of Korea

Related
1 trials

Shared therapeutic areas:

Helicobacter Pylori Infection
Similarity Score15%

Ivan FN Hung, MD FRCP

The University of Hong Kong

Related
12 trials

Shared therapeutic areas:

Helicobacter Pylori Infection
Similarity Score15%

Publications (0)

No publications found for this investigator.

Clinical Trials (7)

Showing 7 of 7 trials

NCT05332444Phase 4PrincipalInvestigator

Efficacies of Susceptibility-guided vs Empiric Therapy for Rescue Treatment of Helicobacter Pylori Infection

Helicobacter Pylori Infection
Recruiting
NCT03897244Phase 4PrincipalInvestigator

Efficacies of HDDT With or Without Bismuth vs Amoxicillin-metronidazole BQT for First-line H Pylori Eradication

Helicobacter Pylori Infection
Completed
NCT02490839Phase 4PrincipalInvestigator

Efficacy of High-dose Dual Therapy vs Bismuth-containing Quadruple Therapy for Rescue Treatment of Hp Infection

Helicobacter Pylori Infection
Completed
NCT01163435Phase 4PrincipalInvestigator

Efficacy of High Dose Dual Therapy, Sequential Therapy and Triple Therapy in H. Pylori Eradication

Helicobacter Infection
Completed
NCT01265069Phase 4PrincipalInvestigator

Efficacy of 10-day Concomitant Regimen Versus High Dose Dual Therapy in Anti-Helicobacter Pylori Rescue Therapy

Helicobacter Pylori Infection
Unknown
NCT01933659Phase 3PrincipalInvestigator

Anti-H. Pylori Effect of Deep See Water

Helicobacter Pylori Infection
Completed
NCT02483715Phase 4PrincipalInvestigator

Efficacy of High-dose Dual Therapy vs Bismuth-containing Quadruple Therapy for First-line Treatment of Hp Infection

Helicobacter Pylori Infection
Completed

All 7 trials loaded